A phase II trial of gemcitabine plus capecitabine for patients with advanced pancreatic adenocarcinoma

By Park Byeong-Bae   Park Joon   Lee Hyo   Lee Jeeyun   Choi Dong   Choi Seong-Ho   Heo Jin   Lee Jong   Lee Kyu   Lim Do   Park Young   Lim Ho-Yeong   Kang Won   Park Keunchil  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 489-494

Springer Publishing Company

Access to resources Recommend Favorite

A phase II trial of docetaxel and CPT-11 in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and gastric cardia

By Jatoi Aminah   Tirona Marisa   Cha Steven   Alberts Steven   Rowland Kendrith   Morton Roscoe   Nair Suresh   Kardinal Carl   Stella Philip   Mailliard James   Sargent Daniel   Goldberg Richard  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 115-123

Humana Press, Inc

Access to resources Recommend Favorite

Phase II trial of vinorelbine in patients with advanced and/or recurrent cervical carcinoma: an EORTC Gynaecological Cancer Cooperative Group Study

By Lhomme C.   Vermorken J.B.   Mickiewicz E.   Chevalier B.   Alvarez A.   Mendiola C.   Pawinski A.   Lentz M.A.   Pecorelli S.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 194-199

Elsevier

Access to resources Recommend Favorite

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

By Esteban E.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 127-133

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas

By Stevenson J.P.   Scher R.M.   Kosierowski R.   Fox S.C.   Simmonds M.   Yao K.-S.   Green F.   Broom C.   Fields S.Z.   Krebs J.B.   O'Dwyer P.J.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1358-1362

Elsevier

Access to resources Recommend Favorite